Authors: Kavanaugh, AF Lipsky, PE

Citation: Af. Kavanaugh et Pe. Lipsky, Inhibitors of tumor necrosis factor, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 313-326

Authors: Furst, DE Breedveld, FC Burmester, GR Crofford, JJ Emery, P Feldmann, M Kalden, JR Kavanaugh, AF Keystone, EC Klareskog, LG Lipsky, PE Maini, RN Russell, AS Scott, DL Smolen, JS Van de Putte, LBA Visher, TL Weisman, MH

Citation: De. Furst et al., Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000), ANN RHEUM D, 59, 2000, pp. 1-2

Authors: Kavanaugh, AF

Citation: Af. Kavanaugh, Treatment options for rheumatoid arthritis, AM J M CARE, 5(14), 1999, pp. S845-S851

Authors: Kavanaugh, AF Wolfe, F Ward, M

Citation: Af. Kavanaugh et al., New treatments for rheumatoid arthritis: A managed care perspective - Questions and answer session, AM J M CARE, 5(14), 1999, pp. S866-S869

Authors: Kavanaugh, AF Wolfe, F Auslander, M Bresloff, T Clark, DL Hillman, D Lewis, DL Martinez, L Milgram, L Newcomer, D Nguyen, T Rae, J

Citation: Af. Kavanaugh et al., Roundtable II: Cost concerns for rheumatoid arthritis treatment, AM J M CARE, 5(14), 1999, pp. S880-S888